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Brief Communications

A Novel Hap1–Tsc1 Interaction Regulates Neuronal
mTORC1 Signaling and Morphogenesis in the Brain
Luis A. Mejia,1,2 Nadia Litterman,1,2* Yoshiho Ikeuchi,1,3* Luis de la Torre-Ubieta,1,2 Eric J. Bennett,4 Chi Zhang,1
J. Wade Harper,4 and Azad Bonni1,2,3
1Department of Neurobiology, Harvard Medical School, Boston, Massachusetts 02115, 2Program in Neuroscience, Harvard Medical School, Boston,
Massachusetts 02115, 3Department of Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri 63110, and 4Department
of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115

Tuberous sclerosis complex (TSC) is a leading genetic cause of autism. The TSC proteins Tsc1 and Tsc2 control the mTORC1 signaling
pathway in diverse cells, but how the mTORC1 pathway is specifically regulated in neurons remains to be elucidated. Here, using an
interaction proteomics approach in neural cells including neurons, we uncover the brain-enriched protein huntingtin-associated protein
1 (Hap1) as a novel functional partner of Tsc1. Knockdown of Hap1 promotes specification of supernumerary axons in primary hippocampal neurons and profoundly impairs the positioning of pyramidal neurons in the mouse hippocampus in vivo. The Hap1
knockdown-induced phenotypes in primary neurons and in vivo recapitulate the phenotypes induced by Tsc1 knockdown. We also find
that Hap1 knockdown in hippocampal neurons induces the downregulation of Tsc1 and stimulates the activity of mTORC1, as reflected
by phosphorylation of the ribosomal protein S6. Inhibition of mTORC1 activity suppresses the Hap1 knockdown-induced polarity
phenotype in hippocampal neurons. Collectively, these findings define a novel link between Hap1 and Tsc1 that regulates neuronal
mTORC1 signaling and neuronal morphogenesis, with implications for our understanding of developmental disorders of cognition.

Introduction
Tuberous sclerosis complex (TSC) is a developmental disorder
and leading genetic cause of autism. Neurological manifestations
of TSC include epilepsy, autistic disorder, intellectual disability
(ID), learning disabilities, and behavioral disturbances (Orlova
and Crino, 2010). Because our understanding of the pathogenesis
of TSC is poor, treatment options for patients with these disorders remain inadequate.
Mutations of the TSC1 or TSC2 genes cause TSC (Orlova and
Crino, 2010). The TSC1 and TSC2 proteins centrally regulate the
mTORC1 signaling pathway. The TSC1-TSC2 dimer inhibits the
mTORC1 activator, Rheb. Loss of TSC1-TSC2 function activates
the mTORC1 pathway, which normally drives protein synthesis
in response to diverse signals (Ma and Blenis, 2009). Deregulated
protein synthesis stemming from perturbation of the mTORC1
pathway is associated with seizures and learning and behavior
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deficits in animals, and mutations in TSC1, TSC2, PTEN, eIF4E,
and FMRP in autism and ID suggest that deregulation of the
mTORC1 pathway plays a role in the pathogenesis of these brain
disorders (Santini et al., 2013). However, how the mTORC1
pathway is specifically regulated in neurons remains largely
unexplored.
The advent of computation-assisted interaction proteomics led
us to systematically search for binding partners of autism spectrum
disorder (ASD)- and ID-linked proteins. Using multiple parallel affinity purifications and the CompPASS analysis platform (Sowa et
al., 2009), we applied an immunoprecipitation-mass spectrometry
(IP-MS) approach in neurons. Here, we identify the protein Hap1 as
a novel binding partner of Tsc1. Hap1, a 67 kDa or 70 kDa protein (A
or B rodent isoforms, respectively), was originally identified as an
interactor of the protein Huntingtin (Li et al., 1995). Hap1 may
regulate the trafficking of microtubule- and membrane-associated
protein cargoes in neurons. In this function, Hap1 is thought to
promote protein recycling and prevent protein degradation (Rong et
al., 2007; Sheng et al., 2008). Interestingly, Hap1 expression appears
to be largely limited to neural tissues (Dragatsis et al., 2000). We
found that Hap1 knockdown promotes the specification of supernumerary axons in hippocampal neurons, and Hap1 knockdown in
the developing hippocampus impairs the positioning of pyramidal
neurons in vivo, mimicking the effect of Tsc1 knockdown. In biochemical assays, Hap1 knockdown triggers the downregulation of
endogenous neuronal Tsc1 and stimulates phosphorylation of the
mTORC1-regulated ribosomal protein S6. In epistasis analyses, inhibition of mTORC1 by rapamycin or an active form of Tsc2 suppresses the Hap1 knockdown-induced phenotype in neurons.
Together, these data identify a novel function for Hap1 in the regu-
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Figure 1. Identification of Hap1 as a novel Tsc1-interacting protein. A, IP-MS-CompPASS of Tsc1 in neuro2a and cortical neurons. Lysates of stable FLAG-Tsc1-expressing neuro2a or FLAG-Tsc1
lentivirus-infected cortical neurons were FLAG resin-immunoprecipitated. Bait complexes were analyzed by LC MS/MS. Analysis was done in CompPASS against dedicated neuro2a or cortical neuron
IP-MS databases. High-confidence interacting proteins had normalized weighted D (NWD) scores ⬎1. Total appearances across unrelated parallel IP-MS bait-runs are shown (“Ratio”). “Spectral
counts” represent the number of tryptic peptides detected by the mass spectrometer corresponding to each protein. B, Reciprocal coimmunoprecipitations of Hap1 and (Figure legend continues.)
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lation of neuronal mTORC1 signaling and consequent neuronal
morphogenesis.

Materials and Methods
All animal work was approved by the Harvard Institutional Animal Care
and Use Committee.
Immunoprecipitation-mass spectrometry (IP-LC-MS/MS). IP-MS was
performed as described (Sowa et al., 2009), with modifications. Mouse
neuro2a cells or rat DIV5 primary cortical neurons were infected with
lentiviruses encoding individual FLAG-tagged baits. The neuronal synapsin1 promoter (Syn-pHAGE-N-FLAG vector) was used in cortical
neurons. Puromycin resistance selected for stable expression in neuro2a.
Lysates of neuro2a or DIV10 cortical neurons were subjected to immunoprecipitation using FLAG resin (Sigma), followed by 3XFLAG peptide
elution (Sigma) and TCA precipitation. Proteins were trypsinized
(Sequencing-Grade Trypsin, Promega) and washed (3M Empore C18
media), and tryptic peptides were loaded onto an LTQ linear ion trap
mass spectrometer (ThermoFinnigan). Spectra were searched against
target-decoy mouse or rat tryptic peptide databases. CompPASS analysis
was done against dedicated neuro2a (⬎60 bait-runs) or cortical neuron
(⬎40 bait-runs) IP-MS databases.
Plasmids. ORFs for IP-MS were subcloned by Gateway recombination
into pHAGE-N-FLAG lentiviral vector. pRK7-FLAG-human TSC1 and
TSC2 were from J. Blenis; pcdna3-FLAG-TSC2 Ser939Ala/Thr1462Ala
was from Addgene. Rat Hap1 was amplified from P6 rat brain cDNA.
shRNAs were expressed from pBluescript-U6 or subcloned into pLentiLox 3.7 for lentivirus. Rat shRNAs are as follows: Hap1i.1, GCTGCAGAGAGGAACGAAAGA; Hap1i.2, CACCGAAGATGATATCAAAGT;
Hap1i.3, AGCTGAAACTGCTGGAAGAAG; Hap1i.4, GCTCCTACATGCAGGATTATG; Tsc1i.1, CTAAAGAGCTTTCTGAGATCA. Mouse
shRNAs are as follows: scrambled control, TACGCGCATAAGATTAGGGTA;
Hap1i.1, GAAGAAGATCACCGAAGATGA; Hap1i.2, CACCGAAGATGATATCAAAGT; Tsc1i3, GATTATTACCTGGAAACCAAT.
Antibodies. Tsc1 (#4906), Tsc2 (D93F12, #4308), phosphoS6 235/236
(D57.2.2E, #4858), total S6 (5G10, #2217), and Erk (#9102) antibodies
were from Cell Signaling Technologies. Hap1 antibody (#611302) was
from BD Biosciences. Tau1 antibody (PC1C6, #MAB3420) was from
Millipore. The GFP antibody was produced in rabbit using recombinant
GFP. The tubulin antibody (neuronal ␤-III, TUJ1, #MMS-435P) was
from Covance.
Coimmunoprecipitation analyses in HEK293T cells. Coimmunoprecipitations were performed as described (Litterman et al., 2011). Lysates
were prepared in 1% Triton-X, 0.05% SDS, 0.025% deoxycholate, 150
mM NaCl, 50 mM Tris-HCl, 2 mM EDTA.
Hippocampal culture, transfection, lentiviral infection. Hippocampal
cultures and transfections were done 2 h after plating as described (de la
Torre-Ubieta et al., 2010). For biochemistry, neurons were plated at
4
(Figure legend continued.) Tsc1. First and second panels from left, Lysates of HEK293T transfected with FLAG-Tsc1 and Myc-Hap1B were subjected to immunoprecipitation followed by
immunoblotting. Myc-Hap1 interacted with FLAG-Tsc1 and increased FLAG-Tsc1 protein abundance. Third panel from left, Lysates of HEK293T transfected with FLAG-Tsc2 and Myc-Hap1B
were subjected to immunoprecipitation followed by immunoblotting. Right, Lysates of
HEK293T transfected with FLAG-Tsc1, HA-Tsc2, and Myc-Hap1B were subjected to immunoprecipitation and immunoblotting. HA-Tsc2 was coexpressed to obtain equal levels of Tsc1 because
Hap1 expression increases Tsc1 protein abundance. C, Endogenous coimmunoprecipitation of
Hap1 and Tsc1. Lysates of E18 mouse brain or neuro2a were subjected to immunoprecipitation
followed by immunoblotting. D, Tsc1 deletion mutant coimmunoprecipitation analyses. Lysates of HEK293T transfected with FLAG-Tsc1 deletion mutants and Myc-Hap1B were subjected
to immunoprecipitation using FLAG antibody, followed by immunoblotting using Myc antibody. Deletion of Tsc1 coiled-coil domain (⌬CC) but not Tsc2-binding domain (⌬TSC2BD), Tsc1
N terminus (⌬Nterm), or the C-terminal 167 amino acids (data not shown), reduced the interaction with Hap1, suggesting that interaction is mediated through Tsc1 coiled-coil domain. E,
Hap1 coimmunoprecipitation analyses. Lysates of HEK293T transfected with Myc-Hap1B
coiled-coil (CC) fragments and FLAG-Tsc1 were subjected to immunoprecipitation using Myc
antibody followed by immunoblotting using FLAG antibody. Hap1 coiled-coil domain 3 (CC3
alone) was sufficient to interact with Tsc1.
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1.0 ⫻ 10 6 cells/well, and lentiviral infection was performed 2 h after
plating. Lysates were prepared in 1% Triton-X, 0.1% SDS, 0.05 deoxycholate, 150 mM NaCl, 50 mM Tris-HCl, 2 mM EDTA.
Hippocampal in utero electroporation. Electroporation of hippocampal
germinal zone was performed as described (Navarro-Quiroga et al.,
2007). E15 embryos of either sex were injected into the lateral ventricle (2
g/L RNAi plasmid, 0.5 g/L pCAG-Venus-IRES-GFP) and electroporated along an ear-to-ear axis and slight rostrocaudal axis (6 pulses, 35
V for 50 ms, 950 ms intervals). Pups developed until P3. Brains were fixed
in 4% sucrose/4% formaldehyde, and cryoprotected in 30% sucrose; 40
m coronal cryosections were prepared.
Immunostaining. Immunostaining was performed as described (de la
Torre-Ubieta et al., 2010).
Statistical analyses. Statistics were performed in GraphPad Prism. Pairwise comparisons within multiple groups were done by two-way
ANOVA followed by Bonferroni post hoc test. Percentage data in histograms are presented as mean ⫾ SEM.

Results
Identification of Hap1 as a novel Tsc1 interactor
To identify novel Tsc1 signaling mechanisms in neurons, we applied an IP-MS-based interaction proteomics approach in neural
cells using CompPASS (Sowa et al., 2009). We expressed FLAGtagged Tsc1 in mouse neuro2a cells or primary rat cortical neurons. Lysates were subjected to immunoprecipitation using
FLAG resin, and eluted trypsinized bait complexes were subjected to LC-MS/MS. The resulting protein assignments were
analyzed in CompPASS, wherein we compared the set of proteins
that copurified with Tsc1 against a large number of parallel
IP-MS datasets generated in mouse neuro2a or primary rat cortical neurons. These analyses led to the identification of highconfidence interacting proteins distinct from background.
We found that Tsc1 copurified the proteins Tsc2 and Tbc1d7
as high-confidence interactors (Fig. 1A), which are known interactors of Tsc1 (Dibble et al., 2012), validating our IP-MS
approach. We also uncovered the protein Hap1 as a novel highconfidence interactor of Tsc1 in both neuro2a cells and primary
neurons (Fig. 1A). The expression of Hap1 is enriched in the
brain and largely limited to nervous system cells (Dragatsis et al.,
2000), suggesting that Hap1 may represent a neural cell-specific
partner of Tsc1.
We validated the Hap1–Tsc1 interaction. Exogenous Hap1
and Tsc1 coimmunoprecipitated in a reciprocal fashion in cells
(Fig. 1B). Exogenous Hap1 also promoted the abundance of the
coexpressed Tsc1 protein (Fig. 1B). Importantly, endogenous
Hap1 and endogenous Tsc1 formed a complex in neuro2a cells
and in mouse brain (Fig. 1C). Notably, a proportion, but not all,
of endogenous Hap1 interacted with endogenous Tsc1. In other
analyses, Hap1 also copurified the Tsc1 partner protein Tsc2 (Fig.
1 B, C), suggesting that Hap1 forms a complex with the Tsc1-Tsc2
dimer.
We mapped the domains that mediate the interaction of Tsc1
and Hap1. Deletion of the entire N-terminal region upstream of
the Tsc1 coiled-coil domain (1–721), the Tsc2-binding region
(302– 430) (Hodges et al., 2001), or the C-terminal 167 amino
acids (997–1164) of Tsc1 had little or no effect on the interaction
with Hap1 (Fig. 1D; and data not shown). By contrast, deletion of
the Tsc1 coiled-coil domain (721–997) reduced the interaction of
Tsc1 with Hap1 (Fig. 1D). In analyses of Hap1, the Hap1 coiledcoil domain 3 (CC3; 354 – 417) was sufficient to interact with
Tsc1. In contrast, coiled-coil domains 1 and 2 (CC1,2; 254 –354)
failed to associate with Tsc1 (Fig. 1E). Together, these data suggest that Hap1 and Tsc1 interact in cells and in the brain, and that
the interaction occurs through coiled-coiled domains.
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Figure 2. Hap1 and Tsc1 regulate hippocampal pyramidal neuron axon specification and positioning. A, Lysates of hippocampal neurons from 0 to 5 DIV were subjected to immunoblotting using
the Tsc1, Hap1, or Tubulin (␤-III type) antibody. B, E18 rat hippocampal neurons transfected 2 h after plating with the control U6 RNAi or Hap1 RNAi or Tsc1 RNAi plasmids were subjected to
immunocytochemistry on DIV5 using the GFP (green) and the axonal antigen Tau1 (red) antibodies. Scale bar, 20 m. The i.1, i.2, i.4 nomenclature refers to individual shRNAs. C, Quantification of
axon specification as percentage of neurons. Hap1 or Tsc1 knockdown promoted specification of supernumerary axons (n ⫽ 3 experiments). ***p ⬍ 0.001 (two-way ANOVA and post hoc Bonferroni
test). No axon spec., neurons that failed to specify a Tau1-immunoreactive axon. D, Lysates of HEK293T cells transfected with Myc-Hap1 and control U6 RNAi or Hap1 RNAi (top) or DIV5 hippocampal
neurons infected 2 h after plating with U6 RNAi or Tsc1 RNAi (bottom) were subjected to immunoblotting. E, E15 mice were electroporated with Hap1 RNAi, Tsc1 RNAi, or scrambled control RNAi and
VENUS-IRES-EGFP plasmids. Brains were harvested on P3 and subjected to immunohistochemistry using the GFP (green) antibody and Hoechst 33258 (purple). Scale bar, 50 m. SP, Stratum
pyramidale; SO, stratum oriens. F, Quantification of neuronal position as percentage of neurons. Knockdown of Tsc1 or Hap1 impaired neuronal positioning into the SP in the hippocampus in vivo
(n ⱖ 3). ***p ⬍ 0.001 (two-way ANOVA and post hoc Bonferroni test). Number of animals analyzed per condition is shown. G, Lysates of mouse neuro2a cells transfected for 3 d with control U6 RNAi,
Hap1 RNAi, or Tsc1 RNAi were subjected to immunoblotting.

Hap1 regulates axon specification and positioning of
hippocampal pyramidal neurons
Having identified Hap1 as a Tsc1 interactor, we asked whether
these proteins shared biological roles in neurons. Both Tsc1

and Hap1 were expressed in hippocampal neurons (Fig. 2A).
Their levels increased from DIV0 to DIV5 (Fig. 2A), which
coincides temporally with the specification and outgrowth of
axons. To probe for a role of Hap1 in axon development, we
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Hap1 regulates Tsc1 abundance and
mTORC1 signaling in neurons
We next determined a mechanism by
which Hap1 might regulate Tsc1 function
in cells. Tsc1 protein is not expressed at a
high level in cells in the absence of coexpressed Tsc2 resulting from low solubility
and stability (Nellist et al., 1999). Expression
of Hap1 strongly promoted the abundance
of coexpressed Tsc1, mimicking the effect of
Tsc2 coexpression (Figs. 1B and 3A). Importantly, lentivirus-mediated knockdown
of Hap1 triggered downregulation of endogenous Tsc1 in hippocampal neurons
(Fig. 3B). The extent of Tsc1 downregulation correlated with the extent of Hap1
knockdown (Fig. 3B). Because Tsc1-Tsc2 is
an essential negative regulator of mTORC1
signaling, we assessed the role of Hap1 in
regulating the mTORC1 pathway in
neurons. Knockdown of Hap1 in hippocampal neurons stimulated phosphorylation of the mTORC1 effector protein S6
(Fig. 3C). Together, these data suggest that
Hap1 promotes the abundance of Tsc1 and
inhibits neuronal mTORC1 signaling.
We next assessed the role of mTORC1
signaling on Hap1-mediated control of
Figure 3. Hap1 controls Tsc1 abundance and S6 phosphorylation. A, Lysates of HEK293T cells transfected with FLAG-Tsc1 alone hippocampal neuron development. Inhibior FLAG-Tsc1 together with FLAG-Tsc2 or Myc-Hap1B were subjected to immunoblotting. Coexpression of Myc-Hap1B or FLAG- tion of mTORC1 by rapamycin suppressed
Tsc2 promoted FLAG-Tsc1 abundance. Arrow indicates location of Tsc1. B, Lysates of DIV5 hippocampal neurons infected on DIV0 the specification of supernumerary axons
2 h after plating with Hap1 RNAi or control lentivirus cultured under basal conditions were subjected to immunoblotting. Hap1 induced by Hap1 knockdown and reknockdown triggered downregulation of Tsc1 and Tsc2. The i.1, i.3 nomenclature refers to individual shRNAs. C, Lysates of DIV5 stored single-axon polarity in these neuhippocampal neurons infected on DIV0 2 h after plating with RNAi cultured under basal conditions were subjected to immunorons (Fig. 4 A, B). Rapamycin had little or
blotting. Hap1 knockdown triggered downregulation of Tsc1 and Tsc2 and stimulated phosphorylation of the mTORC1 effector S6.
no effect on single axon specification in
control neurons (Fig. 4B), suggesting a
specific suppression of the Hap1 knockused a plasmid-based method of RNAi (Gaudilliere et al.,
down effect. In complementary experiments, inhibition of
2002). Knockdown of Hap1 in hippocampal neurons promTORC1 by expression of an active form of Tsc2, in which
moted the specification of more than one axon per neuron
inhibitory Akt phosphorylation sites (Ser939/Thr1462) were re(Fig. 2 B, C). The Hap1 knockdown-induced phenotype recaplaced with alanine (Tsc2 SA/TA) (Manning et al., 2002), suppitulated the effect of Tsc1 knockdown, which led to the specpressed the specification of supernumerary axons and restored
ification of supernumerary axons (Fig. 2 B, C) (Choi et al.,
single-axon polarity in Hap1 knockdown neurons (Fig. 4C,D).
2008). These data suggest that Hap1 and Tsc1 suppress axon
Together, these data suggest that Hap1 regulates neuronal morspecification in hippocampal neurons.
phogenesis upstream of neuronal mTORC1, by promoting Tsc1
We determined the role of Hap1 in hippocampal neuron defunction and inhibiting mTORC1 signaling.
velopment in vivo. Because the establishment of axon-dendrite
Discussion
polarity is critical for proper migration and positioning of developing pyramidal neurons (Barnes and Polleux, 2009; de la TorreIn this study, we have identified a novel Hap1–Tsc1 signaling
Ubieta and Bonni, 2011), we reasoned that Hap1 and Tsc1 might
link that controls the mTORC1 pathway in neurons. Accordinfluence neuronal positioning in the hippocampus in vivo.
ingly, depletion of Hap1 promotes specification of supernumerUsing in utero electroporation in embryonic day 15 (E15)
ary axons in hippocampal neurons and profoundly impairing
mice, we found that pyramidal neurons in control mice at
the positioning of hippocampal pyramidal neurons in vivo.
postnatal day 3 (P3) completed migration through the stratum
We have also elucidated a mechanism by which Hap1 regulates
oriens and incorporated into the pyramidal cell layer (Fig.
neuronal Tsc1 function. Hap1 knockdown triggers the down2 E, F ). In contrast, pyramidal neurons in Hap1 knockdown
regulation of Tsc1 and activates the mTORC1 signaling pathway in
animals failed to reach the pyramidal cell layer, and their soma
hippocampal neurons. Consistent with these findings, inhibiremained within the stratum oriens (Fig. 2 E, F ). Notably, Tsc1
tion of mTORC1 signaling suppresses the Hap1 knockdownknockdown phenocopied the impairment of pyramidal neuinduced axon phenotype in neurons. Our findings uncover
ron positioning in the hippocampus induced by Hap1 knockHap1 as a novel regulator of neuronal Tsc1-Tsc2/mTORC1
down (Fig. 2 E, F ). Collectively, our data suggest that both
signaling and define a critical role for the Hap1–Tsc1 interacHap1 and Tsc1 regulate axon-dendrite morphogenesis and
tion in the control of axon development and neuronal posipositioning of hippocampal pyramidal neurons.
tioning in the brain.
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Hap1 represents, to our knowledge,
the first identified neural-specific molecular regulator of mTORC1 signaling. This
finding suggests the interesting possibility
that disruption of neuron-specific regulators of mTORC1 signaling might contribute to the pathogenesis of neurological
manifestations of TSC, including autism,
intellectual disability, and epilepsy.
The identification of Hap1 as a novel
interactor of Tsc1 should shed light on the
regulation of the neuronal Tsc1-Tsc2
complex. Tsc1 and Tsc2 depend on each
other for their solubility and stability, and
loss of either protein or dissociation of the
Tsc1-Tsc2 dimer impairs mTORC1 signaling (Orlova and Crino, 2010; Dibble et
al., 2012). Studies in non-neural cells suggest that the Tsc1-Tsc2 complex also contains the protein Tbc1d7 (Nakashima et
al., 2007; Dibble et al., 2012). Our IP-MS
analyses revealed that Tbc1d7 also interacts with Tsc1 in neurons, suggesting that
the Tsc1-Tbc1d7-Tsc2 complex may form
in neurons. It will be interesting to determine whether Hap1 might cooperate with
Tbc1d7 or Tsc2 to regulate the abundance
of Tsc1 in neurons and thereby regulate
neuronal mTORC1 signaling.
Tsc1-Tsc2 and mTORC1 pathway
components control axon development
and pyramidal neuron morphogenesis
(Han and Sahin, 2011). Loss of Tsc1-Tsc2
leads to abnormal axon development and
neuronal polarization and positioning, along
with dendritic arbor defects in the cerebral
cortex (Choi et al., 2008; Li et al., 2008; Feliciano et al., 2011; Goto et al., 2011). Our study Figure 4. Hap1 regulates axon specification upstream of mTORC1 signaling. A, E18 hippocampal neurons transfected 2 h after
suggests Hap1 regulates pyramidal neuron plating and treated with 20 nM rapamycin or DMSO vehicle on DIV1 and DIV3 were subjected to immunocytochemistry on DIV5.
axon specification and positioning and Scale bar, 20 m. B, Quantification of axon specification as a percentage of neurons from A. Rapamycin suppressed specification
strengthens the link between axon-dendrite of supernumerary axons in Hap1-knockdown neurons (n ⫽ 3 experiments). ***p ⬍ 0.001 (two-way ANOVA and post hoc
Bonferroni test). n.s., not statistically different. C, E18 hippocampal neurons transfected 2 h after plating with Hap1 RNAi and
polarization and neuron positioning.
SA/TA
or vector control plasmids were subjected to immunocytochemistry on DIV5. D, Quantification of axon specification as a
The identification of an intimate Hap1– Tsc2
percentage of neurons from C. Expression of Tsc2 SA/TA suppressed specification of supernumerary axons in Hap1-knockdown
Tsc1 connection bears implications for both neurons (n ⫽ 3 experiments). ***p ⬍ 0.001 (two-way ANOVA and post hoc Bonferroni test). n.s., not statistically different.
Hap1 and mTORC1 signaling beyond the
control of axon morphogenesis and neuronal
play a role in the control of cognitive and neurological function.
positioning. It will be interesting to determine the role of Hap1 in
Remarkably, recent whole-exome sequencing has identified a
the control of long-term depression and hippocampal excitatory/
rare complete Hap1 knock-out among patients with ASD (Lim et
inhibitory balance, which are regulated by Tsc1 (Bateup et al.,
al., 2013), suggesting that Hap1 may be relevant to ASD patho2013). Conversely, it will be interesting to investigate whether
genesis. Elucidation of a Hap1-TSC1 signaling link in ASD may
Tsc1 may influence Hap1 functions, including regulation of
expand our understanding of the molecular components at play
GABAA receptor surface expression (Rong et al., 2007).
in ASD pathogenesis.
Our study demonstrates that multibait IP-MS interaction
proteomics approaches can be performed in primary neurons.
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